CAICaris Life Sciences, Inc.

$5B

Q2 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$59M+7.3% YoY

Gross Profit

$37M62.9% margin

Operating Income

$23M39.3% margin

Net Income

$13M21.7% margin

EPS (Diluted)

$0.60

QoQ Revenue Growth

+1.5%

Cash Flow

Operating Cash Flow

$35M

Free Cash Flow

-$114M

Stock-Based Comp.

$457,000

Balance Sheet

Total Assets

$2.0B

Total Liabilities

$1.5B

Stockholders' Equity

$473M

Cash & Equivalents

$61M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$59M	$55M	+7.3%
Gross Profit	$37M	$36M	+3.0%
Operating Income	$23M	$23M	+1.6%
Net Income	$13M	$13M	-4.1%

CAI Q2 2015 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena